Anti-tumor therapy | Solid tumour | Haematological malignancy | ||||||
---|---|---|---|---|---|---|---|---|
death | severe COVID-19 | death | severe COVID-19 | |||||
OR (95%CI) | P | OR (95%CI) | P | OR (95%CI) | P | OR (95%CI) | P | |
Chemotherapy | 1.17 (1.03–1.34) | 0.0158 | 1.16 (0.81–1.66) | 0.4072 | 1.41 (0.74–2.68) | 0.2964 | NA | NA |
Radiotherapy | NA | NA | NA | NA | NA | NA | NA | NA |
Targeted therapy | NA | NA | NA | NA | NA | NA | NA | NA |
Surgery | NA | NA | NA | NA | NA | NA | NA | NA |
Endocrine therapy | NA | NA | NA | NA | NA | NA | NA | NA |
Immunotherapy | 0.91 (0.47–1.76) | 0.7705 | NA | NA | NA | NA | NA | NA |
Antitumor therapy | 1.15 (0.94–1.42) | 0.1815 | 1.08 (0.88–1.32) | 0.4643 | 1.26 (0.91–1.75) | 0.1597 | NA | NA |